glp-1 psoriatic arthritis Frontiers Targeting the GLP-1/GLP-1R axis to
Description
This presentation aims to review key considerations in subcutaneous drug delivery and demonstrate how various needle parameters (length, external and internal diameters, bevel etc.) can impact injection performance, patient self-injection experience, and accuracy of targeting the subcutaneous layer across different patient populations
The biggest external factor is regulatory: compounded GLP-1 availability is in transition under FDA enforcement, and anyone starting a program in June 2026 should understand what that means for supply continuity
Physiology 31 (3), 233245
This and other information is in the fund page within the website (www.quantifyfunds.com)
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men
The peak area of GLP-1RAs in the dissolved precipitate was detected by HPLC
